Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic inflammation, heart and liver diseases, diabetes, neurodegenerative diseases, etc. Although such health benefits have not been consistently observed in some intervention trials, positive results from clinical trials have provided direct evidence supporting the cancer-protective effect of green tea. In addition, numerous mechanisms of action have been suggested to contribute to tea's disease-preventive effects. Furthermore, effects of the processing and storage of tea, as well as additives on tea's properties have been investigated.
Subjects
polyphenols cell cycle arrest and apoptosis neuroblastoma salivary ?-amylase activity cancer apoptosis yaupon holly bioaccessibility fracture p53 tea Liubao tea BE(2)-C matrix metalloproteinase-1 (MMP-1) catechin renal stone oxalate protein expression 67LR Alzheimer's disease EGCG nutraceutical diseases anti-oxidant heme oxygenase-1 polyphenol anxiety matcha ERCC1/XPF neuro-sphere tea consumption theanine Rosmarinic acid yerba mate hypercalciuria gene expression microbiota cohort study histone deacetylase 2 (HDAC2) guayusa nuclear factor erythroid 2-related factor 2 (Nrf2) DNA repair mRNA expression caffeine chemoprevention cisplatin 6-OH-11-O-hydroxyphenanthrene adrenal hypertrophy hepatic damage anti-photoaging cell death green tea kudingcha suberoylanilide hydroxamic acid (SAHA) epigallocatechin gallate (EGCG) stress-reduction calcium oxalate monohydrate Camellia sinensis chemoresistance tea polyphenols green tea polyphenols green tea catechins N-MYC cancer epigallocatechin-gallate (EGCG) Parkinson's disease